Publications by authors named "Suzana Ilic"

Deoxynivalenol (DON), a frequent mycotoxin worldwide, impairs human and animal health. The response of microRNAs, small non-coding RNAs, to DON has been scarcely investigated, but holds remarkable potential for biomarker applications. Hence, we aimed to investigate DON-induced changes in the microRNA expression in porcine liver, jejunum and serum by combining targeted and untargeted analyses.

View Article and Find Full Text PDF

Phytogenics are plant-based feed additives utilized in animal nutrition to support animal growth and health. Worldwide restrictions and bans on the use of antibiotic growth promoters resulted in an increased demand for in-feed alternatives including phytogenics. However, several challenges remain for technology readiness in animal industry, especially regarding the standardization of the ingredients as well as our knowledge on the cellular mechanisms underlying their biological effects.

View Article and Find Full Text PDF

Antibiotics have played a critical role in sustaining and improving livestock production in the past decades, but the emergence of antimicrobial resistance has led several countries to ban or limit their use. Since then, in-feed alternatives have gained a lot of attention but the development of efficacious alternatives implies a better understanding of the mode of action of antibiotic growth promoters (AGP) when administered at subtherapeutic concentrations. In the present study, 120 broiler chickens per group (8 pens/group) were fed for 35 d with either basal feed (control group) or feed supplemented with avilamycin (AGP group; 10 g/1,000 kg of feed).

View Article and Find Full Text PDF

Positive effects of exercise on cancer prevention and progression have been proposed to be mediated by stimulating natural killer (NK) cells. Because NK cell receptors are regulated by epigenetic modifications, we investigated whether acute aerobic exercise and training change promoter DNA methylation and gene expression of the activating and the inhibiting gene. Sixteen healthy women (50-60 years) performed a graded exercise test (GXT) and were randomized into either a passive control group or an intervention group performing a four-week endurance exercise intervention.

View Article and Find Full Text PDF
Article Synopsis
  • Biomarkers that can predict how well breast cancer patients will respond to bevacizumab treatment are currently lacking, prompting this study to explore the role of DNA methylation patterns in treatment outcomes.
  • Researchers analyzed methylation data from samples of 36 HER2-negative metastatic breast cancer patients who received chemotherapy with bevacizumab, identifying gene loci that differed significantly between responders and non-responders.
  • The study developed a predictive model using a 9-gene signature and a refined 3-gene model, both of which could effectively distinguish between patients who responded to treatment and those who did not, indicating promising potential for personalized treatment approaches.
View Article and Find Full Text PDF